Approval · Notice of Compliance 486 · 2003
BIO-DIAZEPAM: Notice of Compliance 486
Issued February 13, 2003
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 486
- Date
- February 13, 2003
- Company
- Biomed 2002 Inc
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- New manufacturer and product name
- Therapeutic class
- Anxiolytic / relaxant
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| BIO-DIAZEPAM | 02247173 | Cancelled Post Market |
| BIO-DIAZEPAM | 02247174 | Cancelled Post Market |
| BIO-DIAZEPAM | 02247176 | Cancelled Post Market |